Lv31
400 积分 2023-02-27 加入
A Single-Arm Phase II Study of Envafolimab Combined with Chemoradiotherapy and Recombinant Human Endostatin in High-risk Locally Advanced Nasopharyngeal Carcinoma
5小时前
已完结
Bevacizumab and platinum-based combinations for recurrent ovarian cancer: a randomised, open-label, phase 3 trial
1个月前
已完结
Ovarian cancer
1个月前
已完结
Efficacy and safety of immune checkpoint inhibitors combined with recombinant human endostatin and chemotherapy as the first-line treatment of advanced non-small-cell lung cancer
6个月前
已完结
Pembrolizumab in combination with gemcitabine and cisplatin compared with gemcitabine and cisplatin alone for patients with advanced biliary tract cancer (KEYNOTE-966): a randomised, double-blind, placebo-controlled, phase 3 trial
7个月前
已完结
皖公网安备34019202002308
